Testing a ketamine-related drug for short-term pain in healthy adults
Treatments studied
Part of Pain clinical trials.
This study tests whether a new drug called (2R,6R)-HNK can reduce pain caused by heat in healthy volunteers. The results will help researchers understand if this drug might be useful for treating acute (short-lasting) pain in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You are in overall good health
- You can receive medication through an IV (a needle in your arm)
- If you could become pregnant, you must use highly effective birth control during the study and for 4 weeks after
- If you could cause pregnancy, you must use condoms or other effective birth control during the study and for 90 days after
- You can follow study rules and attend all visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new experimental drug (2R,6R)-HNK, a chemical related to ketamine, given by IV infusion to see if it can help people with depression that hasn't improved with other treatments. The goal is to find a new option for people who have not found relief from standard antidepressants.
This Phase 1/2 study tests hydroxynorketamine (a related ketamine-type medicine) to see if it can reduce chronic nerve pain in the arms or legs. You may be able to join if you have nerve pain for more than 3 months and meet safety and health check requirements.
This study tests a new investigational drug called HRS-6257 in healthy volunteers. It looks at how the drug works in the body and checks for side effects after one or several doses.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This study tests a new pain medication called KHN702 for people with moderate to severe pain after surgery. It aims to see if the drug is safe and effective at relieving post-operative pain.
This trial tests a new long-acting painkiller called HYR-PB21 to see how it compares to the standard drug bupivacaine. Healthy volunteers will receive one dose and be monitored for safety and how the drug moves through their body.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.